Careful glucose monitoring is essential for patient self-management of IR and T2D. In one recent study, 70% of patients with T2D who tested themselves daily were able to keep their A1C's below 8%. Among those who did not, only 18% maintained A1C's below 8% (Harris MI, et al. Diabetes Care 1999; 22:403–408).